JMKX005425
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for JMKX005425, covering 2025-12-01 to 2025-12-01. Get the full timeline:
Most recent: Clinical Trial Update: A Study of JMKX005425 in Patients With MSI-H/dMMR Advanced Solid Tumors [Phase 1]